India · Delayed Price · Currency is INR Intra-Cellular Therapies Statistics
Total Valuation
BOM:538835 has a market cap or net worth of INR 130.16 billion. The enterprise value is 125.88 billion.
| Market Cap | 130.16B |
| Enterprise Value | 125.88B |
Important Dates
The last earnings date was Friday, July 25, 2025.
| Earnings Date | Jul 25, 2025 |
| Ex-Dividend Date | Jul 18, 2025 |
Share Statistics
| Current Share Class | 139.05M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 76.78M |
Valuation Ratios
The trailing PE ratio is 36.89 and the forward PE ratio is 27.71.
| PE Ratio | 36.89 |
| Forward PE | 27.71 |
| PS Ratio | 5.02 |
| PB Ratio | 4.62 |
| P/TBV Ratio | 6.52 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 35.68 |
| EV / Sales | 4.85 |
| EV / EBITDA | 29.64 |
| EV / EBIT | 32.93 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.17 |
| Debt / FCF | n/a |
| Interest Coverage | 84.37 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.94% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 4.52M |
| Profits Per Employee | 614,527 |
| Employee Count | 5,741 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:538835 has paid 1.18 billion in taxes.
| Income Tax | 1.18B |
| Effective Tax Rate | 24.95% |
Stock Price Statistics
The stock price has decreased by -0.89% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -0.89% |
| 50-Day Moving Average | 1,125.49 |
| 200-Day Moving Average | 887.38 |
| Relative Strength Index (RSI) | 29.39 |
| Average Volume (20 Days) | 15,091 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:538835 had revenue of INR 25.95 billion and earned 3.53 billion in profits. Earnings per share was 25.01.
| Revenue | 25.95B |
| Gross Profit | 10.13B |
| Operating Income | 3.85B |
| Pretax Income | 4.71B |
| Net Income | 3.53B |
| EBITDA | 4.08B |
| EBIT | 3.85B |
| Earnings Per Share (EPS) | 25.01 |
Balance Sheet
The company has 5.31 billion in cash and 717.78 million in debt, giving a net cash position of 4.59 billion.
| Cash & Cash Equivalents | 5.31B |
| Total Debt | 717.78M |
| Net Cash | 4.59B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 28.17B |
| Book Value Per Share | 202.00 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 39.04%, with operating and profit margins of 14.84% and 13.59%.
| Gross Margin | 39.04% |
| Operating Margin | 14.84% |
| Pretax Margin | 18.14% |
| Profit Margin | 13.59% |
| EBITDA Margin | 15.73% |
| EBIT Margin | 14.84% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 7.00, which amounts to a dividend yield of 0.74%.
| Dividend Per Share | 7.00 |
| Dividend Yield | 0.74% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | 0.07% |
| Shareholder Yield | 0.81% |
| Earnings Yield | 2.71% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |